Menu
No results found.
Weekly Share Price & Valuation Overview
Swedencare AB (publ)
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care products, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name. In addition, the company offers dental product for dogs and cats under the ProDen PlaqueOff name; pharmaceutical grade health products for dogs, cats, and horses under the nutravet name; range of products to improve the health and life of pets under the Animal Pharmaceuticals name; premium dog treat offerings, such as jerky and baked biscuit, as well as nutritional supplements for skin and coat health, ear care, and liver support under the Riley's Organics name; and Rx Vitamins for Pets. Further, it provides animal wellness and healthy aging neutraceuticals under the MedVant name; VetWorthy, a solution for specific animal needs and conditions; and Healthy Solutions for Pets, a solution to address a range of pet issues and needs. The company distributes its products through veterinarians and pet stores, as well as online. Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malmö, Sweden.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Earnings growth ≥10% supports improving profitability trajectory.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Market Cap Total equity value of the company (share price × shares outstanding).
- SEK 5.82B
- Enterprise Value Operating value: market cap + total debt − cash.
- SEK 7.50B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- SEK 2.60B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- SEK 1.49B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- SEK 443.30M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- SEK 16.36
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 0.41
- Shares Outstanding
- 159.84M
- Float Shares
- 29.05M
- Implied Shares Outstanding
- 159.84M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
6.58%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
17.03%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
57.17%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
2.49%
- ROA Return on assets: net income ÷ total assets.
-
1.09%
- ROE Return on equity: net income ÷ shareholder equity.
-
0.89%
- Revenue Growth Year-over-year revenue growth.
-
2.60%
- Earnings Growth (YoY) Strong Year-over-year earnings growth.
-
30.00%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.33
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.26
- Total Cash Cash and equivalents.
- SEK 124.00M
- Total Debt Short + long-term interest-bearing debt.
- SEK 1.81B
- Net Debt Total debt − cash (negative = net cash).
- SEK 1.69B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 4.08
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- SEK 336.90M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- SEK 234.70M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
12.94%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
9.02%
- Cash Conversion (OpCF/EBITDA)
- 0.76
- Dividend Yield suppressed due to an anomalous value from the feed (>30%).
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.